Embryo cryopreservation is the process of cooling fertilised eggs to cryogenic temperatures for long-term storage, with the intention of warming and transferring them in a future cycle. It is now a standard component of IVF treatment in accredited fertility laboratories worldwide, and the technology has advanced to the point where frozen embryo transfer cycles achieve clinical outcomes comparable to and in some cases exceeding those of fresh transfer cycles.
The dominant method of embryo cryopreservation in clinical practice is vitrification. The embryo is exposed to cryoprotectant agents in a precisely controlled sequence that removes intracellular water and replaces it with cryoprotectant, before being loaded onto a carrier device and plunged directly into liquid nitrogen at -196°C. The cooling rate achieved – in the range of 15,000 to 30,000°C per minute depending on the carrier design – is fast enough to bypass the temperature range at which ice crystal nucleation occurs. The embryo enters a glass-like amorphous solid state rather than forming damaging ice crystals.
Live birth rates after embryo cryopreservation were reported at 41% per transfer cycle according to a study published by Oxford University Press, with ongoing technological improvements in vitrification techniques continuing to enhance outcomes.
The factors that determine embryo cryopreservation success fall into three categories. Pre-freezing embryo quality is the most significant determinant – a chromosomally normal blastocyst that has developed well in culture has a high probability of surviving vitrification and achieving implantation after warming. The vitrification process itself, including the cryoprotectant protocol, carrier design, and embryologist technical skill, influences the rate of cellular damage during the cooling process. Post-vitrification storage quality determines whether the embryo maintains its preserved state until warming, requiring consistent maintenance of temperatures below -130°C.
The cryogenic storage element of embryo cryopreservation is often overlooked in clinical quality discussions. A vitrification procedure that achieves the glassy state perfectly can still result in sample loss if the subsequent storage is compromised by vacuum failure, LN2 supply disruption, or inadequate monitoring.
Cryolab supplies LN2 storage vessels, vitrification consumables, and cryogenic canes for embryo cryopreservation programmes globally. Browse the storage vessel range or contact the Cryolab team.
